Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2024-09-12 INCY / Incyte Corporation 4 Tray Thomas S - Sale D 62.94 -572
2024-09-12 INCY / Incyte Corporation 4 Dickinson Jonathan Elliott S - Sale D 62.37 -7,333
2024-09-04 MXCT / MaxCyte, Inc. 4 Erck Stanley C S - Sale D 3.97 -29,767
2024-09-04 MXCT / MaxCyte, Inc. 4 Erck Stanley C M - Exercise D 0.04 29,767
2024-09-03 MXCT / MaxCyte, Inc. 4 Erck Stanley C S - Sale D 4.10 -17,922
2024-09-03 MXCT / MaxCyte, Inc. 4 Erck Stanley C M - Exercise D 0.04 17,922
2024-09-01 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -1,666
2024-08-31 ABSI / Absci Corporation 4 Jonasson Zachariah F - Taxes D 4.40 -20,775
2024-08-27 IQV / IQVIA Holdings Inc. 4 Sherbet Eric S - Sale D 246.33 -1,300
2024-08-26 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 4.28 -3,000
2024-08-26 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.926 3,000
2024-08-23 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. S - Sale D 390.73 -3,774
2024-08-23 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 42.62 3,774
2024-08-22 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. S - Sale D 390.73 -4,353
2024-08-22 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 42.62 4,353
2024-08-15 NEO / NeoGenomics, Inc. 4 Olivo Alicia C S - Sale D 16.0533 -1,040
2024-08-15 NEO / NeoGenomics, Inc. 4 Smith Christopher M F - Taxes D -33,130
2024-08-12 INCY / Incyte Corporation 4 Stein Steven H S - Sale D 60.63 -11,608
2024-08-12 CRL / Charles River Laboratories International, Inc. 4 FOSTER JAMES C G - Gift D -2,500
2024-08-10 NEO / NeoGenomics, Inc. 4 Kelly Michael Aaron M - Exercise D 11,336
2024-08-10 NEO / NeoGenomics, Inc. 4 Zook Anthony P. M - Exercise D 11,336
2024-08-10 NEO / NeoGenomics, Inc. 4 HANNAH ALISON L. M - Exercise D 11,336
2024-08-10 NEO / NeoGenomics, Inc. 4 Floegel Elizabeth M - Exercise D 11,336
2024-08-10 NEO / NeoGenomics, Inc. 4 KANOVSKY STEPHEN M M - Exercise D 11,336
2024-08-10 NEO / NeoGenomics, Inc. 4 TETRAULT LYNN A. M - Exercise D 11,336
2024-08-10 NEO / NeoGenomics, Inc. 4 Gunn Neil M - Exercise D 11,336
2024-08-10 NEO / NeoGenomics, Inc. 4 Perez David Brian M - Exercise D 11,336
2024-08-10 NOTV / Inotiv, Inc. 4 Landman David A - Award D 27,500
2024-08-10 NOTV / Inotiv, Inc. 4 Beattie John Gregory A - Award D 20,000
2024-08-10 NOTV / Inotiv, Inc. 4 Castetter Andrea A - Award D 20,000
2024-08-10 NOTV / Inotiv, Inc. 4 Taylor Beth A - Award D 20,000
2024-08-10 NOTV / Inotiv, Inc. 4 Hardy Adrian A - Award D 20,000
2024-08-10 NOTV / Inotiv, Inc. 4 Neff R Matthew A - Award D 27,500
2024-08-10 NOTV / Inotiv, Inc. 4 Harrington Michael J A - Award D 27,500
2024-08-10 NOTV / Inotiv, Inc. 4 Sagartz John E A - Award D 20,000
2024-08-10 NOTV / Inotiv, Inc. 4 Krupp Jeffrey Arthur A - Award D 20,000
2024-08-10 NOTV / Inotiv, Inc. 4 Freeman Jeffrey Brennan A - Award D 20,000
2024-08-10 NOTV / Inotiv, Inc. 4 Leasure Robert Jr. A - Award D 300,000
2024-08-10 NOTV / Inotiv, Inc. 4 Brown Nigel A - Award D 27,500
2024-08-10 NOTV / Inotiv, Inc. 4 Coelho Mary Theresa A - Award D 27,500
2024-08-08 CRL / Charles River Laboratories International, Inc. 4 LaPlume Joseph W S - Sale D 199.36 -1,780
2024-08-05 MEDP / Medpace Holdings, Inc. 4 BURWIG SUSAN E M - Exercise D 90.65 50,000
2024-08-02 MXCT / MaxCyte, Inc. 4 Ross Thomas M. S - Sale D 4.361 -17,857
2024-08-02 MXCT / MaxCyte, Inc. 4 Ross Thomas M. M - Exercise D 1.641 17,857
2024-08-01 MXCT / MaxCyte, Inc. 4 Ross Thomas M. S - Sale D 4.54 -15,476
2024-08-01 CRL / Charles River Laboratories International, Inc. 4 FOSTER JAMES C S - Sale D 250.00 -25,000
2024-08-01 MXCT / MaxCyte, Inc. 4 Ross Thomas M. M - Exercise D 1.641 15,476
2024-08-01 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -14
2024-07-28 IQV / IQVIA Holdings Inc. 4 Patel Bhavik F - Taxes D 239.67 -83
2024-07-28 IQV / IQVIA Holdings Inc. 4 Cherofsky Keriann F - Taxes D 239.67 -35
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)